Regadenoson Injection, Solution
Product Images NDC 0641-6253

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Regadenoson (NDC 0641-6253). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Regadenoson Structural Formula (Regadenoson Injection 1)

FDA Label Image

Regadenoson Injection 0.4 mg Per 5 mL (0.08 mg/ml) Syringe Label (Regadenoson Injection 2)

FDA Label Image

Regadenoson Carton (Regadenoson Injection 3)

FDA Label Image

Representative Serialization Image (Regadenoson Injection 4)

Representative Serialization Image (Regadenoson Injection 4)
This text contains product identification and tracking information, including a Global Trade Item Number (GTIN), serial number (SN), expiration date (EXP), and lot number (LOT).*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.